Department of Medicine Archive — Page 51 of 119
-
March 24, 2022
Berlin named interim leader of Hematology and Oncology
Jordan Berlin, MD, has been appointed interim leader of Vanderbilt's Division of Hematology and Oncology in the Department of Medicine. -
March 24, 2022
Reducing obesity-related inflammation
A treatment that increases levels of lipid signaling molecules reduced adipose tissue inflammation in obese adults, suggesting this pathway may be a valuable target for modulating fat and systemic inflammation. -
March 24, 2022
High blood pressure genes improve heart surgery survival in children
Vanderbilt researchers have found that children with a genetic makeup that predicts high blood pressure as adults are more likely to survive congenital heart defect repair surgery. -
March 17, 2022
U.S. precision medicine research program releases genomic data
The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants. -
March 17, 2022
Blood test figures in cancer risk for people with HIV
A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer. -
March 17, 2022
Ferrell lands Mark Foundation for Cancer Research award
Vanderbilt's Brent Ferrell, MD, is one of the recipients a 2022 Endeavor Award from the The Mark Foundation for Cancer Research. -
March 17, 2022
Study compares kidney injury risk for COVID, flu patients
A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.